title: Refractory polymyositis responding to infliximab: extended follow-up.
authors.forename: I
authors.initials: I
authors.lastname: Labioche
authors.forename: E
authors.initials: E
authors.lastname: Liozon
authors.forename: B
authors.initials: B
authors.lastname: Weschler
authors.forename: V
authors.initials: V
authors.lastname: Loustaud-Ratti
authors.forename: P
authors.initials: P
authors.lastname: Soria
authors.forename: E
authors.initials: E
authors.lastname: Vidal
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D017285:Polymyositis / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D005938:Glucocorticoids; D000069285:Infliximab